Systematic Reviewhigh evidence
Impacts of menopausal hormone therapy on Alzheimer's disease biomarkers: A systematic review.
Journal of Alzheimer's disease : JAD·June 16, 2026·PMID 42300694
Why it mattersIt clarifies that MHT's impact on AD biomarkers is not uniform but depends on formulation, route, and timing, helping neurologists counsel women on potential neuroprotective strategies and interpret biomarker changes in the context of hormone therapy.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled